Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

JC He; RP McLaughlin; V van der Noord; John Foekens; John Martens; G van Westen; YH Zhang; B van de Water

doi:10.1007/s10549-019-05380-z

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

JC He, RP McLaughlin, V van der Noord, John Foekens, John Martens, G van Westen, YH Zhang, B van de Water

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

8 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	263-274
Number of pages	12
Journal	Breast Cancer Research and Treatment
Volume	178
Issue number	2
DOIs	https://doi.org/10.1007/s10549-019-05380-z
Publication status	Published - 2019

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10549-019-05380-z

Repub_118645_O-A.pdfFinal published version, 2.53 MB

http://hdl.handle.net/1765/118645

Cite this

@article{2a65e0a975464ea08ff2922ae396d204,

title = "Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer",

author = "JC He and RP McLaughlin and {van der Noord}, V and John Foekens and John Martens and {van Westen}, G and YH Zhang and {van de Water}, B",

year = "2019",

doi = "10.1007/s10549-019-05380-z",

language = "Undefined/Unknown",

volume = "178",

pages = "263--274",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

AU - He, JC

AU - McLaughlin, RP

AU - van der Noord, V

AU - Foekens, John

AU - Martens, John

AU - van Westen, G

AU - Zhang, YH

AU - van de Water, B

PY - 2019

Y1 - 2019

U2 - 10.1007/s10549-019-05380-z

DO - 10.1007/s10549-019-05380-z

M3 - Article

C2 - 31388935

SN - 0167-6806

VL - 178

SP - 263

EP - 274

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -